New study predicts how SARS-CoV-2 evades vaccines
Models future SARS-CoV-2 mutations and forecasts their ability to evade immune defenses developed by vaccines and antibody-based treatments
Stay updated with breaking news from Pathogen Readiness. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Models future SARS-CoV-2 mutations and forecasts their ability to evade immune defenses developed by vaccines and antibody-based treatments
This article is part of Harvard Medical School’s continuing coverage of medicine, biomedical research, medical education, and policy related to the
Before the COVID-19 pandemic was officially declared in 2020, Mike Springer had an idea to use a food safety diagnostic tool to detect infectious
The future of medicine can’t come fast enough. By JAKE MILLER Over the past 20 years, revolutionary developments in the fields of genomics, molecular
Strong antibody response to mRNA vaccines declined over an eight-month follow-up period; lower initial response to single-shot Ad26 vaccine remained